MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - indian pharma
- CADILA HEALTHCARE - ACTAVIS (US)
CADILA HEALTHCARE vs ACTAVIS (US) - Comparison Results
CADILA HEALTHCARE Change
Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More
ACTAVIS (US)
Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More
Financials
 CADILA HEALTHCARE  ACTAVIS |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| CADILA HEALTHCARE Mar-20 |
ACTAVIS Dec-18 |
CADILA HEALTHCARE/ ACTAVIS |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 352 | 14,122 | - | |
| Low | Rs | 207 | 9,473 | - | |
| Sales per share (Unadj.) | Rs | 139.2 | 3,464.0 | - | |
| Earnings per share (Unadj.) | Rs | 11.8 | -1,115.8 | - | |
| Cash flow per share (Unadj.) | Rs | 18.6 | 365.0 | - | |
| Dividends per share (Unadj.) | Rs | 3.50 | 0 | - | |
| Dividend yield (eoy) | % | 1.3 | 0 | - | |
| Book value per share (Unadj.) | Rs | 101.4 | 14,287.5 | - | |
| Shares outstanding (eoy) | m | 1,023.74 | 332.60 | - | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 2.0 | 3.4 | 58.9% | |
| Avg P/E ratio | x | 23.7 | -10.6 | -224.6% | |
| P/CF ratio (eoy) | x | 15.0 | 32.3 | 46.6% | |
| Price / Book Value ratio | x | 2.8 | 0.8 | 333.9% | |
| Dividend payout | % | 29.8 | 0 | - | |
| Avg Mkt Cap | Rs m | 286,033 | 3,923,754 | 7.3% | |
| No. of employees | `000 | 13.4 | 16.9 | 79.3% | |
| Total wages/salary | Rs m | 24,145 | 0 | - | |
| Avg. sales/employee | Rs Th | 10,632.7 | 68,173.7 | 15.6% | |
| Avg. wages/employee | Rs Th | 1,801.2 | 0 | - | |
| Avg. net profit/employee | Rs Th | 898.5 | -21,958.8 | -4.1% | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 142,531 | 1,152,135 | 12.4% | |
| Other income | Rs m | 1,139 | 22,033 | 5.2% | |
| Total revenues | Rs m | 143,670 | 1,174,168 | 12.2% | |
| Gross profit | Rs m | 24,198 | 30,192 | 80.1% | |
| Depreciation | Rs m | 6,965 | 492,513 | 1.4% | |
| Interest | Rs m | 3,418 | 66,485 | 5.1% | |
| Profit before tax | Rs m | 14,954 | -506,773 | -3.0% | |
| Minority Interest | Rs m | 288 | 0 | - | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | 129,248 | 0.0% | |
| Tax | Rs m | 3,198 | -6,422 | -49.8% | |
| Profit after tax | Rs m | 12,044 | -371,103 | -3.2% | |
| Gross profit margin | % | 17.0 | 2.6 | 647.9% | |
| Effective tax rate | % | 21.4 | 1.3 | 1,687.5% | |
| Net profit margin | % | 8.5 | -32.2 | -26.2% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 87,154 | 472,546 | 18.4% | |
| Current liabilities | Rs m | 82,694 | 418,029 | 19.8% | |
| Net working cap to sales | % | 3.1 | 4.7 | 66.1% | |
| Current ratio | x | 1.1 | 1.1 | 93.2% | |
| Inventory Days | Days | 71 | 20 | 364.7% | |
| Debtors Days | Days | 94 | 66 | 141.5% | |
| Net fixed assets | Rs m | 133,236 | 130,415 | 102.2% | |
| Share capital | Rs m | 1,024 | 0 | - | |
| Net worth | Rs m | 103,757 | 4,752,020 | 2.2% | |
| Long term debt | Rs m | 32,146 | 1,673,358 | 1.9% | |
| Total assets | Rs m | 236,866 | 7,428,488 | 3.2% | |
| Interest coverage | x | 5.4 | -6.6 | -81.2% | |
| Debt to equity ratio | x | 0.3 | 0.4 | 88.0% | |
| Sales to assets ratio | x | 0.6 | 0.2 | 388.0% | |
| Return on assets | % | 6.5 | -4.1 | -159.2% | |
| Return on equity | % | 11.6 | -7.8 | -148.6% | |
| Return on capital | % | 13.7 | -4.8 | -283.6% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 25,054 | 411,614 | 6.1% | |
| From Investments | Rs m | -10,123 | 226,129 | -4.5% | |
| From Financial Activity | Rs m | -10,942 | -706,454 | 1.5% | |
| Net Cashflow | Rs m | 3,989 | -68,368 | -5.8% | |
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 72.98 Rs / USD
Compare CADILA HEALTHCARE With: MYLAN (US) ADCOCK INGRAM (S. Africa) TEVA PHARMA (Israel)
Compare CADILA HEALTHCARE With: LUPIN FULFORD INDIA CIPLA J.B.CHEMICALS PANACEA BIOTECH
Today's Market
Sensex, Nifty Open Higher; Bajaj Finance & UltraTech Cement Top Gainers(09:30 am)
Asian stock markets are trading on a strong note today. The Hang Seng is trading up by 2% while the Shanghai Composite is up 0.6%. The Nikkei is trading higher by 0.4%.
Related Views On News
CADILA HEALTHCARE 2019-20 Annual Report Analysis (Annual Result Update)
Oct 26, 2020 | Updated on Oct 26, 2020Here's an analysis of the annual report of CADILA HEALTHCARE for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.
CADILA HEALTHCARE Announces Quarterly Results (1QFY21); Net Profit Up 49.3% (Quarterly Result Update)
Aug 21, 2020 | Updated on Aug 21, 2020For the quarter ended June 2020, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (up 49.3% YoY). Sales on the other hand came in at Rs 36 bn (up 4.1% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.
CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)
Nov 15, 2019 | Updated on Nov 15, 2019For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.
More Views on NewsMost Popular
Time to Book Profits in Pharma Stocks (Fast Profits Daily)
Jan 15, 2021In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Smallcap Stocks: Your Best Bet for 2021 and Beyond (Profit Hunter)
Jan 15, 2021The pandemic failed to thwart Richa's investing success formula for 2020.
Buzzing Sectors Before Budget 2021 (Fast Profits Daily)
Jan 12, 2021The budget is just a few weeks away. Which stocks can you expect to move? Find out in this video.
Here's Why Smallcaps Could Be Your Best Investment in 2021 (Profit Hunter)
Jan 12, 2021Select smallcaps hold a great potential to become the multibaggers of tomorrow. Here's how you could get in early into these stocks.
More
